Related references
Note: Only part of the references are listed.Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal
Samra Turajlic et al.
CELL (2018)
Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal
Thomas J. Mitchell et al.
CELL (2018)
Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal
Samra Turajlic et al.
CELL (2018)
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma
Diana Miao et al.
SCIENCE (2018)
Independent association of PD-L1 expression with noninactivated VHL clear cell renal cell carcinomaA finding with therapeutic potential
Solene-Florence Kammerer-Jacquet et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
VHL missense mutations in the p53 binding domain show different effects on p53 signaling and HIFα degradation in clear cell renal cell carcinoma
Caroline Fanja Razafinjatovo et al.
ONCOTARGET (2017)
Renal cell tumors with clear cell histology and intact VHL and chromosome 3p: a histological review of tumors from the Cancer Genome Atlas database
Laura Favazza et al.
MODERN PATHOLOGY (2017)
Treatment of renal cell carcinoma: Current status and future directions
Pedro C. Barata et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Incidence of Clear Cell Papillary Renal Cell Carcinoma in Low-Grade Renal Cell Carcinoma Cases: A 12-Year Retrospective Clinicopathologic Study From a Single Cancer Center
Simpal Gill et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2016)
Characterization of VHL missense mutations in sporadic clear cell renal cell carcinoma: hotspots, affected binding domains, functional impact on pVHL and therapeutic relevance
Caroline Razafinjatovo et al.
BMC CANCER (2016)
Wild-type VHL Clear Cell Renal Cell Carcinomas Are a Distinct Clinical and Histologic Entity: A 10-Year Follow-up
Julien Dagher et al.
EUROPEAN UROLOGY FOCUS (2016)
Clear Cell Renal Cell Carcinoma With Borderline Features of Clear Cell Papillary Renal Cell Carcinoma Combined Morphologic, Immunohistochemical, and Cytogenetic Analysis
Sean R. Williamson et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Clear Cell Papillary Renal Cell Carcinoma and Renal Angiomyoadenomatous Tumor Two Variants of a Morphologic, Immunohistochemical, and Genetic Distinct Entity of Renal Cell Carcinoma
Karl-Friedrich Deml et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
A Clearer View of the Molecular Complexity of Clear Cell Renal Cell Carcinoma
Ian J. Frew et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 10 (2015)
The PI3K/AKT Pathway and Renal Cell Carcinoma
Huifang Guo et al.
JOURNAL OF GENETICS AND GENOMICS (2015)
SETD2 loss-of-function promotes renal cancer branched evolution through replication stress and impaired DNA repair
N. Kanu et al.
ONCOGENE (2015)
Renal cell carcinoma with leiomyomatous stroma-further immunohistochemical and molecular genetic characteristics of unusual entity
Kvetoslava Peckova et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2014)
Clear cell papillary renal cell carcinoma is the fourth most common histologic type of renal cell carcinoma in 290 consecutive nephrectomies for renal cell carcinoma
Haijun Zhou et al.
HUMAN PATHOLOGY (2014)
TCEB1-MUTATED RENAL CELL CARCINOMA: A DISTINCT GENOMIC AND MORPHOLOGIC SUBTYPE
A. Ari Hakimi et al.
JOURNAL OF UROLOGY (2014)
Bap1 is essential for kidney function and cooperates with Vhl in renal tumorigenesis
Shan-Shan Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Clear Cell Papillary Renal Cell Carcinoma–like Tumors in Patients With Von Hippel-Lindau Disease Are Unrelated to Sporadic Clear Cell Papillary Renal Cell Carcinoma
Sean R. Williamson et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia
John R. Srigley et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
SQSTM1 Is a Pathogenic Target of 5q Copy Number Gains in Kidney Cancer
Lianjie Li et al.
CANCER CELL (2013)
Renal cell carcinoma with areas mimicking renal angiomyoadenomatous tumor/clear cell papillary renal cell carcinoma
Fredrik Petersson et al.
HUMAN PATHOLOGY (2013)
Loss of PBRM1 expression is associated with renal cell carcinoma progression
Rafal Pawlowski et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Comprehensivemolecular characterization of clear cell renal cell carcinoma
Chad J. Creighton et al.
NATURE (2013)
Integrated molecular analysis of clear-cell renal cell carcinoma
Yusuke Sato et al.
NATURE GENETICS (2013)
Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivation
L. E. Moore et al.
ONCOGENESIS (2012)
Targeting PD-1/PD-L1 interactions for cancer immunotherapy
Laurence Zitvogel et al.
ONCOIMMUNOLOGY (2012)
VHL Gene Mutations and Their Effects on Hypoxia Inducible Factor HIFα: Identification of Potential Driver and Passenger Mutations
Markus P. Rechsteiner et al.
CANCER RESEARCH (2011)
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
Ignacio Varela et al.
NATURE (2011)
Clonal trisomies 7,10 and 12, normal 3p and absence of VHL gene mutation in a clear cell tubulopapillary carcinoma of the kidney
Alexander Wolfe et al.
VIRCHOWS ARCHIV (2011)
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
Gillian L. Dalgliesh et al.
NATURE (2010)
Patterns of Gene Expression and Copy-Number Alterations in von-Hippel Lindau Disease-Associated and Sporadic Clear Cell Carcinoma of the Kidney
Rameen Beroukhim et al.
CANCER RESEARCH (2009)
Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays
Meng Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
The SWI/SNF complex and cancer
D. Reisman et al.
ONCOGENE (2009)
Renal angiomyoadenomatous tumor: morphologic, immunohistochemical, and molecular genetic study of a distinct entity
M. Michal et al.
VIRCHOWS ARCHIV (2009)
Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancer
Kirsten D. Mertz et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Sporadic clear cell renal cell carcinoma with diffuse cytokeratin 7 immunoreactivity
Kien T. Mai et al.
PATHOLOGY (2008)
Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer
RE Banks et al.
CANCER RESEARCH (2006)
HIF activation identifies early lesions in VHL kidneys: Evidence for site-specific tumor suppressor function in the nephron
SJ Mandriota et al.
CANCER CELL (2002)
Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma:: Relationship to clinicopathological parameters
K Kondo et al.
GENES CHROMOSOMES & CANCER (2002)
CDKN2A mutation analysis, protein expression, and deletion mapping of chromosome 9p in conventional clear-cell renal carcinomas -: Evidence for a second tumor suppressor gene proximal to CDKN2A
P Schraml et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Share Paper
